Individual differences in novelty-seeking predict differential responses to chronic antidepressant treatment through sex- and phenotype-dependent neurochemical signatures

► Novelty-seeking may predict responses to chronic antidepressant treatment. ► Antidepressant effects were evidenced in both sexes but in the opposite phenotypes. ► Male HR rats responded better to chronic clomipramine treatment. ► In males, the neurochemical substrate presented phenotype-related al...

Full description

Saved in:
Bibliographic Details
Published in:Behavioural brain research 2011-09, Vol.223 (1), p.154-168
Main Authors: Pitychoutis, Pothitos M., Pallis, Eleftherios G., Mikail, Hudu G., Papadopoulou-Daifoti, Zeta
Format: Article
Language:English
Subjects:
Adult and adolescent clinical studies
Animals
Antidepressive Agents - administration & dosage
Antidepressive Agents - pharmacology
Behavioral psychophysiology
Biological and medical sciences
Brain - drug effects
Brain - metabolism
Clomipramine
Clomipramine - administration & dosage
Clomipramine - pharmacology
Corticosterone - blood
Depression
Dopamine - metabolism
Drug Administration Schedule
Exploratory Behavior
Female
Female rats
Forced swim test
Fundamental and applied biological sciences. Psychology
Gender
Glutamic Acid - metabolism
Immobility Response, Tonic - drug effects
Individuality
Male
Medical sciences
Mood disorders
Neuropharmacology
Organ Size - drug effects
Pain Threshold - drug effects
Pharmacology. Drug treatments
Phenotype
Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer
Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease)
Psychology. Psychoanalysis. Psychiatry
Psychology. Psychophysiology
Psychopathology. Psychiatry
Psychopharmacology
Rats
Rats, Sprague-Dawley
Serotonin
Serotonin - metabolism
Sex Characteristics
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:► Novelty-seeking may predict responses to chronic antidepressant treatment. ► Antidepressant effects were evidenced in both sexes but in the opposite phenotypes. ► Male HR rats responded better to chronic clomipramine treatment. ► In males, the neurochemical substrate presented phenotype-related alterations. ► Corticosterone levels were boosted in females but attenuated in drug-treated males. Women experience major depression at roughly twice the rate of men. Inconclusive clinical evidences assist the notion that responsiveness to antidepressant pharmacotherapy is sexually dimorphic with the two sexes presenting differential responses when treated with tricyclic antidepressants (TCAs). Notably, responsiveness to antidepressive agents presents marked inter-individual variability, the biological basis of which remains elusive. Herein, we sought to investigate putative sex differences to chronic antidepressant treatment with the TCA clomipramine in rats selected on the basis of their reactions to novelty. Our data revealed that high novelty-seeker (HR) male rats were more responsive to clomipramine treatment as far as the alleviation of anxiety and nociception are concerned, compared to low novelty-seeker (LR) males and HR/LR female rats. Surprisingly, chronic clomipramine treatment attenuated depressive-like symptomatology in the forced swim test (FST) of behavioral despair in both sexes albeit in the opposite novelty-seeking phenotypes (i.e. in male HR and female LR). Interestingly in male HR rats, clomipramine treatment diminished serotonergic neurochemical responses post-FST exposure in all limbic brain regions examined, while these were boosted in their LR counterparts. Dopaminergic and glutamatergic neurochemistry also presented phenotype-related alterations. On the contrary, in females the neurochemical substrate was only modestly affected. Notably, corticosteroid responses were augmented in female but attenuated in male drug-treated rats. Overall, the current dataset lends further support that the male sex may benefit to a greater extent when treated with TCAs and reveals that individual differences are associated with qualitative and quantitative sex-related behavioral and neurochemical manifestations in response to chronic antidepressant treatment.
ISSN:0166-4328
1872-7549
DOI:10.1016/j.bbr.2011.04.036